Votes are taken in meetings of the full ACIP, which are open to the public. Votes are recorded and the vote tally is captured in the ACIP meeting minutes, which are open

to the public and posted on the ACIP website. ACIP members may never undertake full committee deliberations or ERK inhibitor chemical structure voting in a closed meeting, with very rare exceptions (noted above). Depending on the relative importance of the issue, either formal (for example, Delphi, nominal group techniques) or informal methods for soliciting expert opinions are used. Published statements of the ACIP explicitly describe the methods used for developing recommendations and providing the evidence used to develop the recommendations (for example, results of controlled trials, case–control studies, case series, expert opinion, meta-analyses, Delphi surveys, focus groups, cost-effectiveness analyses and other inputs). For an ACIP recommendation to be adopted during voting, a simple majority of voting members is sufficient for the recommendation to be passed by the ACIP. Following adoption Ponatinib in vitro in open meetings of the ACIP, recommendation statements are refined by members of the concerned ACIP WG and then forwarded through CDC’s clearance hierarchy, ultimately to the Office of the CDC Director. Statements must be cleared for technical accuracy,

clarity, and acceptance of policy through all administrative layers of CDC: Branch, Division, Center, Office of the Chief Science Officer, Officer of the Director of CDC. Most recommendations are cleared at the level of the Director of

CDC, who is delegated to adopt immunization policy on behalf of HHS. On rare occasions, the Secretary of HHS may be contacted by the CDC Director for input on clearance, e.g. in the case of a particularly sensitive vaccine or topic. Because ACIP serves in an advisory role to the U.S. Government, CDC/HHS may take the prerogative CYTH4 to revise or reject the recommendations in whole or in part, or to return the topic to ACIP for additional deliberation. In practice, due to the lengthy process of data presentation and review that typically goes on over several months and years before an ACIP vote is ever taken, and because of the extensive input by concerned stakeholders, virtually all ACIP recommendations are adopted by CDC/HHS. In the history of ACIP there has been only one instance when the government did not accept the recommendations voted on by ACIP (2003, recommendations for use of smallpox vaccine in a pre-event vaccination program [8]). In this case, HHS overrode the recommendations of the ACIP. Once the recommendations have been cleared at the level of the CDC Director, recommendation statements are forwarded to the office of CDC’s Morbidity and Mortality Weekly Report, where they undergo careful editing by a designated technical writer-editor.